Product Code: ETC071143 | Publication Date: Jun 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
India infectious disease biomarker testing market is projected to reach US$ 7.44 billion by 2025, registering a CAGR of ~10.12% during 2025-2031 due to the rising prevalence of infectious diseases, increasing demand for personalized medicines and diagnostics, rise in government initiatives towards healthcare infrastructure development and technological advancements. The Indian diagnostic industry has witnessed many changes in the recent years with respect to technology such as automation or molecular techniques which have led to increased accuracy of results thereby driving the growth of the infectious disease biomarker testing market in India.
Increasing prevalence of chronic diseases: The number of people suffering from chronic illnesses like HIV/AIDS, malaria and tuberculosis (TB) is growing rapidly across India leading to an increase in demand for sophisticated diagnostic tests that can detect these infections at an early stage. This has propelled growth within the biodiagnostic industry in India over the past few years. Government support: Various government initiatives are being undertaken such as providing dedicated funds for research activities and making available bio-molecular technologies for diagnosis purposes which are expected to drive further growth within this sector during 2025-2031 period on account of increasing awareness regarding preventive health care amongst public. Technological advancements: Advances made in platform technologies such as Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Mass Spectrometry etc., have enabled more accurate detection methods with improved speed & efficacy thus aiding segmental expansion over time frame stated above.
Limited access/availability of test kits & reagents : Despite various government efforts towards improving healthcare infrastructure & making them accessible even at rural level , availability still remains low thereby creating hindrance particularly among low income groups . Moreover supply chain management also poses major challenges resulting into high cost associated with kits & reagents required for conducting tests effectively . Lack Of Skilled Professionals : Availability Of adequately trained professionals remains limited owing To lack Of education In medical field coupled With limited employment opportunities resulting Into inadequate attention given To emerging needs Of patients leading To failure In achieving desired objectives set forth by public or private organizations respectively.
Growing preference towards home based diagnostics services :To avoid long queues waiting times experienced at hospitals Or clinics , consumers are increasingly opting For home based diagnostics Services Which not only reduces hassle but also safeguards patient?s.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Infectious Disease Biomarker Testing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Infectious Disease Biomarker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 India Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 India Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 India Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 India Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 India Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 India Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Infectious Disease Biomarker Testing Market Trends |
6 India Infectious Disease Biomarker Testing Market, By Types |
6.1 India Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Product, 2018 - 2031F |
6.1.3 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2018 - 2031F |
6.1.4 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2018 - 2031F |
6.1.5 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2018 - 2031F |
6.2 India Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2018 - 2031F |
6.2.3 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2018 - 2031F |
6.2.4 India Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2018 - 2031F |
6.2.5 India Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2018 - 2031F |
6.2.6 India Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2018 - 2031F |
6.2.7 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2018 - 2031F |
6.3 India Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2018 - 2031F |
6.3.3 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2018 - 2031F |
6.3.4 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2018 - 2031F |
6.3.5 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2018 - 2031F |
6.3.6 India Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2018 - 2031F |
7 India Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 India Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 India Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 India Infectious Disease Biomarker Testing Market Key Performance Indicators |
9 India Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 India Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 India Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 India Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 India Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 India Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2024 |
10.2 India Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |